Genmab | Der Umsatz



Sales Veränderung Datum
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Almirall EUR 248.42M 382K 2024-06
Amarin USD 42.3M 25.19M 2024-09
Amgen USD 9.09B 583M 2024-12
argenx SE USD 671.52M 129.45M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Bayer EUR 11.73B 1.76B 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Demant DKK 5.93B 270M 2024-12
Exelixis USD 566.76M 27.21M 2024-12
Fresenius Medical Care EUR 5.07B 250M 2024-12
Galapagos EUR 75.85M 16M 2024-12
Genmab DKK 64.41B 58.87B 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
GN Store Nord DKK 5.02B 860M 2024-12
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
Insmed USD 104.44M 11.02M 2024-12
Lonza CHF 3.52B 460M 2024-12
Merck EUR 5.42B 152M 2024-12
Novartis USD 13.15B 330M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
UCB EUR 3.36B 572M 2024-12



Genmab Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.